{"id":"NCT00212355","sponsor":"Nobelpharma","briefTitle":"Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.","officialTitle":"Phase3, Open-Label, Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-03","primaryCompletion":"2008-04","completion":"2009-01","firstPosted":"2005-09-21","resultsPosted":"2014-05-14","lastUpdate":"2025-03-05"},"enrollment":37,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Wilson's Disease"],"interventions":[{"type":"DRUG","name":"NPC-02","otherNames":[]}],"arms":[{"label":"NPC-02","type":"EXPERIMENTAL"}],"summary":"The purpose of this long-term study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.","primaryOutcome":{"measure":"Safety and Efficacy","timeFrame":"During study period (up to 96W )","effectByArm":[{"arm":"NPC-02","deltaMin":37,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21078496"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":37},"commonTop":["Lipase increased","Nasopharyngitis","Blood iron decreased","Blood amylase increased","Blood urine present"]}}